Los mejores médicos en Turquía — Consiga una consulta online

El contenido cumple con la Política editorial de Bookimed y está revisado médicamente por
Fahad Mawlood - Médico general. Ganador de 4 premios científicos. Sirvió en Asia Occidental. Es el ex jefe del equipo médico que soporta a pacientes de habla árabe. Ahora es responsable del procesamiento de datos y la precisión del contenido médico.
Nail Paksoy
13 años de experiencia
5.0
2 reseñas
Turquía, Estambul
Medipol Bahçelievler Hospital

Nail Paksoy

13 años de experiencia


PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

 

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

 

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

  • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
  • Role: Subinvestigator

2. PFİZER

  • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
  • Role: Subinvestigator

3. RECITE - AMGEN

  • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
  • Role: Subinvestigator

4. NAVIGATE - BAYER

  • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
  • Role: Subinvestigator

5. RUBY - Tesaro (PRA)

  • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
  • Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

  • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
  • Role: Subinvestigator

7. ASTRA ZENECA

  • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
  • Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

  • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
  • Role: Subinvestigator
  •  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
  • Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
  • Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

  • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
  • Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

  • Authors: Paksoy, Nail, et al.
  • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

  • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
  • Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

  • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
  • Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

  • Authors: HAS SIMSEK, Duygu, et al.
  • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

  • Authors: FERHATOGLU, Ferhat, et al.
  • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

  • Authors: GÜRBÜZ, Mustafa, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

  • Authors: AY, Seval, et al.
  • Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

  • Authors: CIL, Ibrahim, et al.
  • Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

  • Authors: HIZAL, Mutlu, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
  • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
  • Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

  • Authors: DEMIR, Semra, et al.
  • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

  • Authors: ÖZDEMIR, Seçil Kepil, et al.
  • Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

  • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
  • Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

  • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
  • Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
  • Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
  • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

  • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
  • Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

  • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
  • Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

  • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
  • Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

  • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
  • Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

  • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
  • Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

 

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

  • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

  • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

  • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

  • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

  • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

  • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

  • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

  • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

 

 

Mostrar más


PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

 

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

 

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

  • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
  • Role: Subinvestigator

2. PFİZER

  • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
  • Role: Subinvestigator

3. RECITE - AMGEN

  • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
  • Role: Subinvestigator

4. NAVIGATE - BAYER

  • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
  • Role: Subinvestigator

5. RUBY - Tesaro (PRA)

  • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
  • Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

  • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
  • Role: Subinvestigator

7. ASTRA ZENECA

  • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
  • Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

  • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
  • Role: Subinvestigator
  •  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
  • Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
  • Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

  • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
  • Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

  • Authors: Paksoy, Nail, et al.
  • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

  • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
  • Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

  • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
  • Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

  • Authors: HAS SIMSEK, Duygu, et al.
  • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

  • Authors: FERHATOGLU, Ferhat, et al.
  • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

  • Authors: GÜRBÜZ, Mustafa, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

  • Authors: AY, Seval, et al.
  • Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

  • Authors: CIL, Ibrahim, et al.
  • Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

  • Authors: HIZAL, Mutlu, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
  • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
  • Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

  • Authors: DEMIR, Semra, et al.
  • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

  • Authors: ÖZDEMIR, Seçil Kepil, et al.
  • Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

  • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
  • Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

  • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
  • Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
  • Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
  • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

  • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
  • Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

  • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
  • Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

  • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
  • Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

  • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
  • Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

  • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
  • Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

 

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

  • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

  • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

  • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

  • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

  • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

  • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

  • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

  • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

 

 

Mostrar más
5.0
2 reseñas
Cita con el médico precio a consultar
Balón gástrico $1500 - $3500
Terapia con yodo radiactivo $5000 - $7000
Mastectomía $5000 - $7500
Más tratamientos
Savas Comlek
28 años de experiencia
Turquía, Estambul
Hospital Florence Nightingale Gayrettepe

Savas Comlek

28 años de experiencia

Personal information

Title: Associate Professor

Branch: Anesthesiology

Work History:

1 Gayrettepe Florence Nightingale Hospital

Medical Specialties and Subspecialties:

1 Waist and Neck Pain

2 Cancer Pains

3 Spine Pains

4 Pain

Education

1991 - Istanbul University Cerrahpaşa Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Anesthesia and Reanimation

Specialization Training

2017 - Fellow of Interventional Pain Practice

2018- Certifield Interventional Pain Sonologist

International Articles

1 ÇÖMLEK SAVAŞ, MUTLU AYHAN, ÖZGÖNENEL EBRU, KAHRAMAN SİNAN, ÖZGÖNENEL LEVENT (2021). Atypical Fem-oral Fracture After Discontinuing Long-Term Bisphosphonate Use. Demiroğlu Bilim University Florence Nightingale

Medical Journal, 7(1), 52-56., Doi: 10.5606/fng.btd.2021.25048

2 POTTERY WAR, ORDU AYLIN (2021). Interventional Pain Management During SARS-CoV-2 Pandemic. Signa Vitae, 17(4),

178-184., doi: 10.22514/sv.2021.008

3 SAVAS COMLEK(2021). Transverse Abdominis Plane Block-Based Multimodal Analgesia Protocol Reduces Tramadol

Need After Cesarean Section. Bağcılar Medical Bulletin, 6(2), 134-141., Doi: 10.4274/BMB.galenos.2021.11.077

4 ÇÖMLEK SAVAS, SAĞLAM SEZER (2021). A New Approach for Leptomeningeal Metastases: Chemotherapy Adminis-

tered Through Lumbar Intrathecal Port. Arquivos de Neuro-Psiquiatria, Doi: 10.1590/0004-282X-ANP-2020-0554

5 SAVAS COMLEK(2021). Treatment Methods for Bone Metastasis-Induced Pain. Turkish Journal of Oncology, 36(1), 73-

78., Doi: 10.5505/tjo.2021.S1019

6 SAVAS COMLEK(2021). Ultrasound-Guided Interventions During Pregnancy for Lumbosacral Pain Unresponsive to Con-

servative Treatment: A Retrospective Review. Journal of Clinical Ultrasound, 49(1), 20-27., Doi: 10.1002/jcu.22923

7 SAVAS COMLEK(2020). Pain Control with Splanchnic Neurolysis in Pancreatic Cancer Patients Unresponsive to Celiac

Plexus Neurolysis. Journal of Pain Research, 13, 2023-2031., doi: 10.2147/JPR.S266689

8 SAVAS COMLEK(2020). Chemotherapy-Induced Pneumonitis Associated with Transient CA 15-3 Elevation. Journal of

Oncology Pharmacy Practice, 26(7), 1750-1753., Doi: 10.1177/1078155220904994

9 RAHİMİ MEHDİ, GÖĞÜZ DEMET, KAYA GÜNER, BOZKURT PERVİN, ÇÖMLEK SAVAŞ (2000). Patient Controlled Analgesia

(PCA) Application in Pediatric Patients. Ağrı, 12(1), 19-26.

10 BOZKURT PERVİN, KAYA GÜNER, TUNALI YUSUF, ÇÖMLEK SAVAŞ (1996). Bradyarrhythmia During Reperfusion in Kidney Transplantations (Case Report). Journal of the Turkish Society of Anesthesiology and Reanimation, 24(2), 92-94.

Mostrar más

Personal information

Title: Associate Professor

Branch: Anesthesiology

Work History:

1 Gayrettepe Florence Nightingale Hospital

Medical Specialties and Subspecialties:

1 Waist and Neck Pain

2 Cancer Pains

3 Spine Pains

4 Pain

Education

1991 - Istanbul University Cerrahpaşa Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Anesthesia and Reanimation

Specialization Training

2017 - Fellow of Interventional Pain Practice

2018- Certifield Interventional Pain Sonologist

International Articles

1 ÇÖMLEK SAVAŞ, MUTLU AYHAN, ÖZGÖNENEL EBRU, KAHRAMAN SİNAN, ÖZGÖNENEL LEVENT (2021). Atypical Fem-oral Fracture After Discontinuing Long-Term Bisphosphonate Use. Demiroğlu Bilim University Florence Nightingale

Medical Journal, 7(1), 52-56., Doi: 10.5606/fng.btd.2021.25048

2 POTTERY WAR, ORDU AYLIN (2021). Interventional Pain Management During SARS-CoV-2 Pandemic. Signa Vitae, 17(4),

178-184., doi: 10.22514/sv.2021.008

3 SAVAS COMLEK(2021). Transverse Abdominis Plane Block-Based Multimodal Analgesia Protocol Reduces Tramadol

Need After Cesarean Section. Bağcılar Medical Bulletin, 6(2), 134-141., Doi: 10.4274/BMB.galenos.2021.11.077

4 ÇÖMLEK SAVAS, SAĞLAM SEZER (2021). A New Approach for Leptomeningeal Metastases: Chemotherapy Adminis-

tered Through Lumbar Intrathecal Port. Arquivos de Neuro-Psiquiatria, Doi: 10.1590/0004-282X-ANP-2020-0554

5 SAVAS COMLEK(2021). Treatment Methods for Bone Metastasis-Induced Pain. Turkish Journal of Oncology, 36(1), 73-

78., Doi: 10.5505/tjo.2021.S1019

6 SAVAS COMLEK(2021). Ultrasound-Guided Interventions During Pregnancy for Lumbosacral Pain Unresponsive to Con-

servative Treatment: A Retrospective Review. Journal of Clinical Ultrasound, 49(1), 20-27., Doi: 10.1002/jcu.22923

7 SAVAS COMLEK(2020). Pain Control with Splanchnic Neurolysis in Pancreatic Cancer Patients Unresponsive to Celiac

Plexus Neurolysis. Journal of Pain Research, 13, 2023-2031., doi: 10.2147/JPR.S266689

8 SAVAS COMLEK(2020). Chemotherapy-Induced Pneumonitis Associated with Transient CA 15-3 Elevation. Journal of

Oncology Pharmacy Practice, 26(7), 1750-1753., Doi: 10.1177/1078155220904994

9 RAHİMİ MEHDİ, GÖĞÜZ DEMET, KAYA GÜNER, BOZKURT PERVİN, ÇÖMLEK SAVAŞ (2000). Patient Controlled Analgesia

(PCA) Application in Pediatric Patients. Ağrı, 12(1), 19-26.

10 BOZKURT PERVİN, KAYA GÜNER, TUNALI YUSUF, ÇÖMLEK SAVAŞ (1996). Bradyarrhythmia During Reperfusion in Kidney Transplantations (Case Report). Journal of the Turkish Society of Anesthesiology and Reanimation, 24(2), 92-94.

Mostrar más
Zeki Dogan
25 años de experiencia

Zeki Dogan

25 años de experiencia
Turquía, Estambul
Risus Clinic
Kadri Sert
16 años de experiencia
Turquía, Esmirna
Centro Médico Ento Surgical

Kadri Sert

16 años de experiencia

After graduating from Fırat University Faculty of Medicine in 2008, he worked as a physician in Şırnak Silopi Health Center No. 3 for 2 years. In 2011, he started his specialization in Manisa Celal Bayar University, Otorhinolaryngology.

 

He completed his specialization in ENT Diseases Specialization in 2016. In 2016, he succeeded in the written and oral exams organized by the Turkish Otorhinolaryngology and Head and Neck Surgery Association and was entitled to receive a Certificate of Proficiency.

 

He worked as an Ear Nose and Throat Diseases Specialist at Manisa Merkez Efendi State Hospital between 2016-2021. He has been working at Private ENTO ENT Surgical Medical Center since October 2021.

Mostrar más

After graduating from Fırat University Faculty of Medicine in 2008, he worked as a physician in Şırnak Silopi Health Center No. 3 for 2 years. In 2011, he started his specialization in Manisa Celal Bayar University, Otorhinolaryngology.

 

He completed his specialization in ENT Diseases Specialization in 2016. In 2016, he succeeded in the written and oral exams organized by the Turkish Otorhinolaryngology and Head and Neck Surgery Association and was entitled to receive a Certificate of Proficiency.

 

He worked as an Ear Nose and Throat Diseases Specialist at Manisa Merkez Efendi State Hospital between 2016-2021. He has been working at Private ENTO ENT Surgical Medical Center since October 2021.

Mostrar más
Cita con el médico precio a consultar
Levantamiento de senos $2934.55 - $3353.77
Abdominoplastia $2305.72 - $2724.94
Cirugía de lifting facial $4192.21 - $5240.27
Más tratamientos
Ramazan Yunus Gul
34 años de experiencia
Turquía, Estambul
Medipol University Pendik Hospital

Ramazan Yunus Gul

34 años de experiencia

Education 

2002 Haydarpaşa Numune Training and Research Hospital, Internal Medicine 

1990 Erciyes University, Faculty of Medicine 

 

Experience 

2019 - 2019 Okan University Hospital 

2018 - 2019 Ibn Sina Hospital 

2003 - 2018 Pendik State Hospital 

1997 - 2003 Haydarpasa Numune Hospital 

1990 - 1994 Erzincan State Hospital 

Istanbul Haydarpasa Numune Hospital 

Kartal Health Group Presidency 

Yıldırım Beyazıt Mother and Child Health Physician 

 

Mostrar más

Education 

2002 Haydarpaşa Numune Training and Research Hospital, Internal Medicine 

1990 Erciyes University, Faculty of Medicine 

 

Experience 

2019 - 2019 Okan University Hospital 

2018 - 2019 Ibn Sina Hospital 

2003 - 2018 Pendik State Hospital 

1997 - 2003 Haydarpasa Numune Hospital 

1990 - 1994 Erzincan State Hospital 

Istanbul Haydarpasa Numune Hospital 

Kartal Health Group Presidency 

Yıldırım Beyazıt Mother and Child Health Physician 

 

Mostrar más
Barbaros Dokumaci
4.0
2 reseñas
Turquía, Estambul
Kolan Hospital Group

Especialista en trastornos cardiovasculares. Utiliza métodos de diagnóstico avanzados.

Mostrar más

Especialista en trastornos cardiovasculares. Utiliza métodos de diagnóstico avanzados.

Mostrar más
Tulin Coskun
4.0
2 reseñas
Turquía, Estambul
Kolan Hospital Group

Se especializa en trastornos neurológicos, tratamiento y rehabilitación. Aborda la epilepsia, los trastornos del sueño, los dolores de cabeza, las enfermedades cerebrovasculares y los problemas de movimiento.

Mostrar más

Se especializa en trastornos neurológicos, tratamiento y rehabilitación. Aborda la epilepsia, los trastornos del sueño, los dolores de cabeza, las enfermedades cerebrovasculares y los problemas de movimiento.

Mostrar más
Serdar Sürmeli
4.0
2 reseñas
Turquía, Estambul
Kolan Hospital Group

El Dr. Serdar Sürmeli se especializa en extirpar tumores de párpados, enfermedades del canal lagrimal, coriorretinitis, ruptura de retina y otros.

Mostrar más

El Dr. Serdar Sürmeli se especializa en extirpar tumores de párpados, enfermedades del canal lagrimal, coriorretinitis, ruptura de retina y otros.

Mostrar más
Ahmet Dogan
4.0
2 reseñas
Turquía, Estambul
Kolan Hospital Group

El médico se especializa en el tratamiento de lesiones deportivas y relacionadas con la edad, cirugía de prótesis y ortopedia pediátrica.

Mostrar más

El médico se especializa en el tratamiento de lesiones deportivas y relacionadas con la edad, cirugía de prótesis y ortopedia pediátrica.

Mostrar más
Bulat Aytek Sik
4.0
2 reseñas
Turquía, Estambul
Kolan Hospital Group

Médico obstetra-ginecólogo, especializado en medicina reproductiva

35 años

  • Completó su especialización de 2005 a 2010 en Estambul en el Hospital de Investigación y Capacitación en Obstetricia y Ginecología.
  • Recibió el Certificado de FIV e Infertilidad de la Universidad de Estambul.
  • Defendió su tesis sobre el tema: "El valor de la evaluación del estado del cuello uterino mediante ultrasonografía transvaginal en la determinación de la respuesta a la inducción dolorosa del parto en gestantes nulíparas con embarazo postérmino"
  • Desde 2015 tiene el título académico de Profesor Asociado.
Mostrar más

Médico obstetra-ginecólogo, especializado en medicina reproductiva

35 años

  • Completó su especialización de 2005 a 2010 en Estambul en el Hospital de Investigación y Capacitación en Obstetricia y Ginecología.
  • Recibió el Certificado de FIV e Infertilidad de la Universidad de Estambul.
  • Defendió su tesis sobre el tema: "El valor de la evaluación del estado del cuello uterino mediante ultrasonografía transvaginal en la determinación de la respuesta a la inducción dolorosa del parto en gestantes nulíparas con embarazo postérmino"
  • Desde 2015 tiene el título académico de Profesor Asociado.
Mostrar más
Sadyk Yildirim
4.0
2 reseñas
Turquía, Estambul
Kolan Hospital Group

Cirujano, oncólogo, especialista en cirugía del aparato digestivo y oncología de la mama.

25 años

  • Ha trabajado en clínicas en los EE.UU. y el Reino Unido.
  • Certificado como especialista en cirugía gastrointestinal por el Johns Hopkins Institute, USA
  • Certificado como especialista en cirugía laparoscópica por el Centro Médico Porte de Choisy, Francia.
  • Director del Colegio Americano de Cirujanos para estudiantes de Turquía.
Mostrar más

Cirujano, oncólogo, especialista en cirugía del aparato digestivo y oncología de la mama.

25 años

  • Ha trabajado en clínicas en los EE.UU. y el Reino Unido.
  • Certificado como especialista en cirugía gastrointestinal por el Johns Hopkins Institute, USA
  • Certificado como especialista en cirugía laparoscópica por el Centro Médico Porte de Choisy, Francia.
  • Director del Colegio Americano de Cirujanos para estudiantes de Turquía.
Mostrar más
Turquía, Estambul
Kolan Hospital Group

Urólogo, especialista en oncourología y endoscopia

20 años

  • Completó su formación avanzada en laparoscopia en Estrasburgo.
  • Se formó en el campo de la oncología y uro-oncología en la Clínica San Rafael en Italia y la Clínica Heilbronn en Alemania.
  • Competente en nefrolitotomía percutánea con mediciones tomográficas 3D preoperatorias.
  • Trata la obstrucción de la salida de la vejiga y la protrusión prostática intravesical (IPP).
Mostrar más

Urólogo, especialista en oncourología y endoscopia

20 años

  • Completó su formación avanzada en laparoscopia en Estrasburgo.
  • Se formó en el campo de la oncología y uro-oncología en la Clínica San Rafael en Italia y la Clínica Heilbronn en Alemania.
  • Competente en nefrolitotomía percutánea con mediciones tomográficas 3D preoperatorias.
  • Trata la obstrucción de la salida de la vejiga y la protrusión prostática intravesical (IPP).
Mostrar más
Hasan Mirzai
4.0
2 reseñas
Turquía, Estambul
Kolan Hospital Group

El Dr. Hasan Mirzai es un profesor médico con experiencia en cirugía cerebral y nerviosa, neurocirugía, cirugía de columna, cirugía de tumores cerebrales y cirugía cerebral pediátrica. Tiene una amplia experiencia en múltiples hospitales y es miembro de la Sociedad Mundial de la Columna Vertebral, la Asociación Médica Turca y la Asociación Turca de Neurocirugía.

Mostrar más

El Dr. Hasan Mirzai es un profesor médico con experiencia en cirugía cerebral y nerviosa, neurocirugía, cirugía de columna, cirugía de tumores cerebrales y cirugía cerebral pediátrica. Tiene una amplia experiencia en múltiples hospitales y es miembro de la Sociedad Mundial de la Columna Vertebral, la Asociación Médica Turca y la Asociación Turca de Neurocirugía.

Mostrar más
Kübra Aydın
4.6
5 reseñas
Turquía, Ankara
Memorial Ankara Hospital
4.6
5 reseñas
Cita con el médico precio a consultar
Abdominoplastia $6000
Cirugía de cáncer de mama $7700
Ablación por radiofrecuencia
Más tratamientos
Emre Acaroglu
4.6
5 reseñas
Turquía, Ankara
Memorial Ankara Hospital

El Dr. Emre Acaroglu es ortopedista y traumatólogo con más de 33 años de experiencia. Es un miembro activo de múltiples organizaciones y ha completado varios programas educativos, ha publicado artículos y libros y se ha presentado en conferencias.

Mostrar más

El Dr. Emre Acaroglu es ortopedista y traumatólogo con más de 33 años de experiencia. Es un miembro activo de múltiples organizaciones y ha completado varios programas educativos, ha publicado artículos y libros y se ha presentado en conferencias.

Mostrar más
4.6
5 reseñas
Cita con el médico precio a consultar
Abdominoplastia $6000
Cirugía de cáncer de mama $7700
Ablación por radiofrecuencia
Más tratamientos
Ali Oto
4.6
5 reseñas
Turquía, Ankara
Memorial Ankara Hospital
El Prof. Dr. Ali Safak Dagli es un cirujano otorrinolaringólogo y otorrinolaringólogo experimentado con más de 31 años de experiencia en enfermedades del oído, nariz y garganta. Tiene experiencia en el tratamiento de cirugía de adenoides, tiroidectomía, miringotomía, cirugía de válvulas nasales, cirugía de oído medio, emisión otoacústica, enfermedades del oído, enfermedades de la laringe y la voz, enfermedades de la boca, garganta y golondrina, enfermedades de los senos paranasales, etc.Mostrar más
El Prof. Dr. Ali Safak Dagli es un cirujano otorrinolaringólogo y otorrinolaringólogo experimentado con más de 31 años de experiencia en enfermedades del oído, nariz y garganta. Tiene experiencia en el tratamiento de cirugía de adenoides, tiroidectomía, miringotomía, cirugía de válvulas nasales, cirugía de oído medio, emisión otoacústica, enfermedades del oído, enfermedades de la laringe y la voz, enfermedades de la boca, garganta y golondrina, enfermedades de los senos paranasales, etc.
Mostrar más
4.6
5 reseñas
Cita con el médico precio a consultar
Abdominoplastia $6000
Cirugía de cáncer de mama $7700
Ablación por radiofrecuencia
Más tratamientos
Yıldız Guney
4.6
5 reseñas
Turquía, Ankara
Memorial Ankara Hospital
4.6
5 reseñas
Cita con el médico precio a consultar
Abdominoplastia $6000
Cirugía de cáncer de mama $7700
Ablación por radiofrecuencia
Más tratamientos
Ferit Avcu
4.6
5 reseñas
Turquía, Ankara
Memorial Ankara Hospital
4.6
5 reseñas
Cita con el médico precio a consultar
Abdominoplastia $6000
Cirugía de cáncer de mama $7700
Ablación por radiofrecuencia
Más tratamientos
Turker Cetin
4.6
5 reseñas
Turquía, Ankara
Memorial Ankara Hospital
4.6
5 reseñas
Cita con el médico precio a consultar
Abdominoplastia $6000
Cirugía de cáncer de mama $7700
Ablación por radiofrecuencia
Más tratamientos
Adem Dervisoglu
4.2
23 reseñas
Turquía, Estambul
Medical Park Göztepe Hospital Complex

El Prof. Dr. Adem Dervişoğlu completó su educación universitaria en la Facultad de Medicina de la Universidad de Ankara y su especialización, doctorado y título de profesor en la Facultad de Medicina de Cerrahpaşa, Universidad de Estambul. También asistió a simposios avanzados y ensayos clínicos sobre tratamiento quirúrgico de la obesidad, técnicas mínimamente invasivas en cirugía visceral y cirugía endocrina respectivamente. Es miembro de la Sociedad Turca de Cirugía, Sociedad de Nutrición Parenteral Enteral Clínica, Sociedad de Hernia, Asociación de Cirugía Endocrina y Asociación de Colon y Recto.

Mostrar más

El Prof. Dr. Adem Dervişoğlu completó su educación universitaria en la Facultad de Medicina de la Universidad de Ankara y su especialización, doctorado y título de profesor en la Facultad de Medicina de Cerrahpaşa, Universidad de Estambul. También asistió a simposios avanzados y ensayos clínicos sobre tratamiento quirúrgico de la obesidad, técnicas mínimamente invasivas en cirugía visceral y cirugía endocrina respectivamente. Es miembro de la Sociedad Turca de Cirugía, Sociedad de Nutrición Parenteral Enteral Clínica, Sociedad de Hernia, Asociación de Cirugía Endocrina y Asociación de Colon y Recto.

Mostrar más
4.2
23 reseñas
Cita con el médico precio a consultar
Cirugía de cáncer de pulmón $9000 - $13000
Resección transnasal de tumor $11500
Banda gástrica $2500 - $5000
Más tratamientos